Funding for this research was provided by:
Australian Research Council (FT140100085)
Health and Medical Research Fund (10111501)
Generalitat Valenciana (GV-2013-087)
Grantová Agentura České Republiky (GA14-2689S and GA17-24378S)
National Heart Foundation of Australia (ID101928 (Future Leader Fellowship), ID100046 (Future Leader Fellowship))
Fonds Wetenschappelijk Onderzoek (FWO12/ASP/102)
Instituto Nacional de Ciência e Tecnologia de Informação Quântica (306836/2011-4)
National Heart, Lung, and Blood Institute (R01HL083454, 5R)1HL111378 02)
Health Research Council of New Zealand (12/329)
Fundo Regional para a Ciência e Tecnologia (SFRH/ BSAB/142983/2018 & UID/DTP/00617/2019)
Madras Diabetes Research Foundation (N/A)
Santander University Scholarship Program 2018 (N/A)
Israel Science Foundations (916/12)
Sir Charles Hercus Research Fellowship - Health Research Council of New Zealand (17/013)
Received: 11 July 2019
Accepted: 20 November 2019
First Online: 3 December 2019
Ethics approval and consent to participate
: Each country obtained ethical approval from their local institutional review boards. Written informed parental consent and student assent for participation was obtained from participants.
: Not applicable.
: JFS received grants and personal fees from the Robert Wood Johnson Foundation outside the submitted work and grants and nonfinancial support from Nike, Inc., outside the submitted work, during the project; receives a stipend from Gopher Sports and royalties from San Diego State University Research Foundation, both related to SPARK physical activity programs, outside the submitted work. The remaining co-authors have no competing interests to declare.